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Separate or combined addition of cyclic AMP-dependent and Ca Z+-linked hormones to isolated rat hepato- 
cytes suspended in a low Ca2+ medium reduced the total cellular Ca. When the hormones were administered 
together, their effects were not additive. This suggests that both types of hormones mobilize Caz+ from a 
common intracellular pool. In the presence of 1.8 mM extracellular Ca 2+, the CaZ+ influx counterbalanced 
or even exceeded the hormone-induced Ca 2+ loss, depending on the ability of the hormones to stimulate 
the CaZ+ influx. 
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1. INTRODUCTION 
In rat liver cells, several hormones like 
vasopressin and angiotensin or the ai-adrenergic 
agonists exert their effects ,by raising the cytosolic 
Ca2+ concentration [l-4]. These agents induce the 
release of Ca2+ from intracellular stores [3-51 and 
enhance the entry of extracellular Ca2+ [4-61. We 
recently demonstrated that addition to liver cell 
preparations of glucagon or cyclic AMP analogues 
together with a Ca2+-dependent hormone 
stimulates the Ca2+ influx synergistically [7]. 
Several reports indicate that glucagon also induces 
either a loss of Ca or a Ca2+ efflux from rat intact 
liver or isolated hepatocytes, suggesting that it 
mobilizes Ca2+ from intracellular stores [8- 121. In 
agreement with these observations, glucagon in- 
creased the cytosplic Ca2+ in rat hepatocytes as 
measured by the quin2 method [l] and this effect 
Abbreviations: BtzcAMP, N6,d-dibutyryladenosine 
3 ’ ,5 ’ -cyclic monophosphate; PIPz, phosphatidylinosi- 
to1 4,5-bisphosphate; IP3, myo-inositol triphosphate 
was also transiently observed in cells suspended in 
a low Ca2+ medium (Berthon, B. and Mauger, 
J.-P., unpublished). Here, we have measured the 
effects of glucagon and cyclic AMP analogues on 
the total cellular Ca content in rat hepatocytes 
suspended in low Ca2+ medium. The results in- 
dicate that by increasing the cellular cyclic AMP 
content, glucagon mobilizes Ca2+ from a pool sen- 
sitive to the Ca’+-dependent hormones. 
2. MATERIALS AND METHODS 
Hepatocytes were isolated from female Wistar 
rats weighing 200-250 g as described [7] and were 
resuspended at 5-7 x lo6 cells/ml in Eagle’s 
medium supplemented with 1.5% gelatin (Difco) 
and 1 mg/ml bacitracin. 
The total hepatocyte Ca content was measured 
essentially as described by Blackmore and Exton 
[ 131 using an atomic absorption spectrophoto- 
meter (Perkin-Elmer model 2380). The results are 
expressed in nmol Ca/mg protein. 
The suppliers of the reagents have already been 
listed [6,7]. 
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3. RESULTS 
Addition of EGTA to the medium reduced the 
total cellular Ca content of the hepatocytes 
(fig.lA). This decrease was partly due to the 
release of Ca*+ from extracellular binding sites, 
and partly to the active extrusion of cytosolic Ca*+ 
by the Ca*+ pump; in low Ca*+ medium, such ex- 
trusion is not counterbalanced by the Ca*+ influx 
[6]. The addition of 10 nM vasopressin accelerated 
the loss of Ca*+ from the cells as expected, since 
this hormone induces the release of Ca*+ from an 
intracellular pool [2-51. This mobilization of Ca*+ 
increases the [Ca*+]i which in turn activates the 
plasma membrane Ca*+ pump [4] and the mobi- 
lized Ca*+ is partly extruded from the cells. 
However, some of this Ca*+ will be taken up into 
a nonionic intramitochondrial Ca pool and will not 
be available for the Ca*+ pump (see [14]). Conse- 
quently the Ca loss from the hepatocytes in the 
absence of Ca*+ influx is essentially indicative of 
the amount of Ca’+ released from the internal 
stores by the Ca*+-dependent hormones but does 
not measure it exactly. 
Addition of 10 nM glucagon also accelerated the 
Ca*+ loss from the hepatocytes, suggesting that 
this hormone also mobilizes intracellular Ca*+ 
(fig.lA). However, the effect of glucagon was 
slower than that of vasopressin, and 5 min after its 
addition, Ca*+ loss was smaller than that caused by 
vasopressin (0.9 vs 1.4 nmol/mg). Fig.lB shows 
the dose-response curve for the effect of glucagon 
on the cell Ca content. The EC50 of the response is 
about 0.2 nM and is in the range of the 
physiological concentrations of glucagon found in 
the plasma. The diterpene forskolin, which ac- 
tivates adenylate cyclase and augments the cellular 
cyclic AMP content, and the permeant cyclic AMP 
analogue BtzcAMP also accelerated the Ca*+ loss 
from cells incubated in low Ca*+ medium in the 
same way as glucagon (table 1). This strongly sug- 
gests that glucagon mobilizes intracellular Ca*+ by 
raising the cellular cyclic AMP content. 
Fig.2A shows that when maximal doses of 
glucagon and vasopressin were simultaneously 
added to the cells, the Ca*+ loss was only slightly 
larger than that observed in the presence of 
glucagon alone and was the same as that observed 
in the presence of vasopressin alone. Therefore the 
effects of glucagon and vasopressin were not ad- 
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Fig.1. Effects of glucagon and vasopressin on the Ca 
content of hepatocytes suspended in a low Ca2+ 
medium. (A) Hepatocytes were preincubated in Eagle’s 
medium containing 1.8 mM Ca’+. 3 mM EGTA was 
added at time 0. After 30 s, vehicle (0) or 10 nM 
glucagon (m) or 10 nM vasopressin (v) was added. At 
the indicated times, l-ml samples of the cell suspension 
were removed for determination of cell Ca. Values are 
means f SE of 9 or 12 determinations in 3 or 4 
experiments. (B) Hepatocytes were incubated as in A 
with the indicated concentration of glucagon. Cell Ca 
was determined 5 min after the addition of glucagon. 
Values are means + SE of at least 6 determinations in at 
least 3 experiments. 
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Table 1 
Effect of BtzcAMP and forskolin on the Ca content of 
hepatocytes uspended in a low Ca2+ medium 
Addition Ca content 
(nmol/mg) 
None 
Vasopressin (lo-* M) 
BtzcAMP (1O-4 M) 
Vasopressin (10m8 M) + 
2.6 Z!I 0.1 
1.4 * 0.1 
1.5 f 0.1 
Bt2cAMP (1O-4 M) 1.4 + 0.1 
DMSO (0.5%) 2.2 f 0.1 
Forskolin (5 x 10m5 M) 1.5 + 0.1 
Hepatocytes were incubated as described in fig.2A. 
Values are means f SE of 6 determinations in 3 
experiments 
ditive, as also observed for the effects of BtzcAMP 
and vasopressin (table 1). This lack of additivity of 
the effects induced by cyclic AMP and the 
Ca2+-linked hormones implies that they mobilize 
Ca2+ from a common intracellular store. Stimula- 
tion of the ,&adrenoceptors by 1 PM isoproterenol 
or 1 ,uM adrenaline in the presence of 10 pM phen- 
tolamine also induced a Ca2+ loss from the 
hepatocytes (fig.2A), as does stimulation of LY- 
adrenoceptors by the addition of 1 pM adrenaline 
in the presence of 10 PM propranolol. When both 
the cy- and ,&adrenoceptors were stimulated by the 
addition of 1 ,uM adrenaline without antagonists, 
the Ca2+ loss was similar to that observed when on- 
ly the a-adrenoceptors were stimulated, indicating 
that the (Y- and fi-adrenergic responses were not 
additive. 
As fig.2B shows, the separate addition of 
glucagon, vasopressin, p- or u-adrenergic agonists 
to cells suspended in a medium containing 1.8 mM 
Ca2+ either had no effect on the total cell Ca con- 
tent, or slightly reduced it. However, simultaneous 
application of glucagon and vasopressin raised the 
cell Ca content as observed by Morgan et al. [ 151. 
These observations indicate that in the presence of 
a normal extracellular Ca2+ concentration, the 
Ca2+ influx partly counterbalances or even exceeds 
the Ca2+ loss resulting from the mobilization of 
Ca2+ from the intracellular pool. We previously 
observed that, when added singly the cyclic AMP- 
dependent and Ca2+-linked hormones stimulated 
the Ca2+ influx in isolated rat hepatocytes, and 
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Fig.2. Effects of glucagon, vasopressin, LY- and ,& 
adrenergic agonists on the Ca content of hepatocytes 
incubated in low or normal Ca2+ medium. (A) 
Hepatocytes were incubated as described in fig.1. 
Hormones were added 30 s after EGTA and samples 
were removed for cell Ca determination 5 min after the 
addition of the hormones. Glucagon (GLU) and 
vasopressin (VP) were added at 10 nM; isoproterenol 
(ISO) and adrenaline (AD) were added at 1 PM. When 
used, phentolamine (PH) and propranolol (PR) were 
added at lOpM, 5 min before the addition of 
adrenaline. (B) As in A except that EGTA was not 
added. Values are means + SE of at least 6 
determinations in at least 3 experiments. 
that when added together, their effect was 
synergistic [6,7]. In fig.3, the difference between 
the total Ca content observed in the presence of ex- 
tracellular Ca’+ (fig.2B) and in its absence (fig.2A) 
has been plotted as a function of the Ca2+ influx, 
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Fig.3. Correlation between the ceB Ca content and the 
Ca*+ influx. The differences in the Ca content observed 
in low and high Cat+ medium were determined from the 
values shown in fig.2A and B. The values for 45Ca2+ 
influx were taken from Mauger et al. 171 and Poggiofi, 
J., Mauger, J.-P. and Claret, M. (submitted). The 
figures indicate the different hormones tested as follows: 
1, none; 2, 1 yM adrenaline + 10 pM phentolamine; 3,
1 PM adrenaline + 10rM propranolol; 4, 1 pM 
isoproterenol; 5, 10 nM glucagon; 6, 1 ,uM adrenaline; 
7, 10 nM vasopressin; 8, 10 nM glucagon + 10 nM 
vasopressin. 
determined with the same hormones from the in- 
itial 45Ca2+ uptake rate. The 2 effects were closely 
correlated, indicating that the Ca2’ influx plays an 
important role in the regulation of the cellular Ca 
content by the hormones in rat hepatocytes. 
4. DISCUSSION 
This report indicates that by increasing cellular 
cyclic AMP content, glucagon accelerates the loss 
of Ca2+ from rat hepatocytes incubated in a low 
Ca2+ medium. This could be due to primary activa- 
tion of the plasma membrane Ca2’ pump. 
However, it has been shown that glucagon or cyclic 
AMP analogues do not increase the ATP- 
dependent Ca2’ transport by plasma membrane 
vesicles [ 16,17]. The other possible explanation of 
our results is that glucagon and the cyclic AMP 
analogues mobilize Cat+ from the same in- 
tracellular pool as the one affected by the addition 
of vasopressin to the cells. In this connection it is 
now known that the Ca’+-linked hormones such as 
vasopressin initiate the degradation of mem- 
branous PIP2 leading to an enhancement of cell 
IP3 content [ 18-211. IP3 in turn r&aSeS Ca2+ from 
the endoplasmic reticulum when it is added to 
permeabilized hepatocytes 122,231 or isolated liver 
microsomes [24], Consequently the present results 
suggest hat cyclic AMP also releases Ca2+ from 
the endoplasmic reticulum in rat hepatocytes. 
There are 3 possible mechanisms by which cyclic 
AMP induces this release. The first hypothesis 
might be that cyclic AMP increases the IP3 content 
of the cells. However, glucagon which increases 
cellular cyclic AMP content does not induce 
measurable degradation of PIP2 or measurable IP3 
production in rat hepatocytes [18,25]. Nevertheless 
we cannot exclude the possibility that cyclic AMP 
produced an amount of IPs too small to be 
detected but sufficient to induce Ca”’ release from 
the endoplasmic reticulum. A second hypothesis 
could be that cyclic AMP inhibits the pumping of 
Ca2+ into the endoplasmic reticulum. But here 
again several reports rather indicated that pretreat- 
ment of the liver or isolated hepatocytes with 
glucagon or cyclic AMP analogues enhanced the 
Ca2’ uptake by the microsomes or endoplasmic 
reticulum-rich fractions [26,27]. The third 
hypothesis is that cyclic AMP increases the efflux 
of Ca2* from the endoplasmic reticulum in the 
same way as IP3. Such an effect of cyclic AMP has 
been described for example in the cardiac sar- 
coplasmic reticulum. In this system cyclic AMP 
appears to increase both active Ca2+ transport into 
the sarcoplasmic reticulum and the Ca2+ efflux 
from this intracellular membrane structure by 
stimulating a cyclic AMP-dependent protein 
kinase. Both these effects are concomitant with the 
phosphorylation of phospholamban (review [ZS]). 
To sum up, our results indicate that in rat 
hepatocytes, glucagon and the cyclic AMP 
analogues induce the release of Ca2+ from the IP3 
sensitive pool, presumably the endoplasmic 
reticulum. The mechanism by which cyclic AMP 
increases the Ca2+ efflux from this compartment 
remains to be elucidated. 
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